According to the agreement, AMP will organize information events in Germany to market Aphria’s branded products to doctors and pharmacists. We are favorable on how the relationship will target a specific group of people and will monitor how it supports the growth of the business over the long-term.

The merger between Aphria and Tilray is expected to be completed in the near future and expect the combined company to be a leader in the global cannabis market.